Glycoconjugate analogues in which the sp -hybridized C2 position of the carbohydrate structure (normally bearing a hydroxy group) is converted into a compact sp -hybridized exomethylene group are expected to have unique biological activities. We established ligand-controlled Tsuji-Trost-type glycosylation methodology to directly prepare a variety of these 2-exomethylene pseudo-glycoconjugates, including glucosylceramide analogues, in an α- or β-selective manner. Glucocerebrosidase GBA1 cleaves these synthetic pseudo-β-glucosylceramides similarly to native glucosylceramides. The pseudo-glucosylceramides exhibit selective ligand activity towards macrophage-inducible C-type lectin (Mincle), but unlike native glucosylceramides, are inactive towards CD1d.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1002/anie.202302569 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!